SCHEMBL20439254

SCHEMBL20439254

CC(C)(C)c1ccccc1C(C)(C)N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.50
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.50
CA2 P00918 1/20 0.46
GABRA1 P14867 1/20 0.39
GABRB2 P47870 1/20 0.39
KIF11 P52732 1/20 0.38
TAAR1 Q96RJ0 2/20 0.37
SLC6A2 P23975 1/20 0.37
GRIN2D O15399 1/20 0.36
GRIN3B O60391 1/20 0.36
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GRIN3A Q8TCU5 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
KCNN4 O15554 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30678520 0.91 ALDH1A1 (0.43) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL48365 0.91 ALDH1A1 (0.43) TDP1ALDH1A1TSHRCA2GABRA1
Methylamine SCHEMBL28294592 0.85 ALDH1A1 (0.57) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL580584 0.85 ALDH1A1 (0.63) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL29355273 0.85 ALDH1A1 (0.63) TDP1ALDH1A1TSHRCA2GABRA1
Hydrochloric Acid SCHEMBL31147078 0.79 ALDH1A1 (0.57) TDP1ALDH1A1TSHRCA2GABRA1
Bromomethane SCHEMBL28461678 0.79 ALDH1A1 (0.57) TDP1ALDH1A1TSHRCA2GABRA1
Methyl Alcohol SCHEMBL28457865 0.79 ALDH1A1 (0.65) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL6458088 0.79 TDP1 (0.46) TDP1ALDH1A1TSHRCA2GABRA1
SCHEMBL4500149 0.79 ALDH1A1 (0.45) TDP1ALDH1A1TSHRGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190256650-A1 CATALYTIC CARBONYLATION CATALYSTS AND METHODS NOVOMER, INC. (US) 2019-08-22 US disclosed
US-20180216107-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256650-A1 CATALYTIC CARBONYLATION CATALYSTS AND METHODS CBR3, CBR1, EPHX2 TDP1 4038/4885ALDH1A1 181/4885TSHR 4642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.